DUBLIN, Oct. 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/cn59hb/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the US Hospital Infectious Disease Testing Market" report to their offering.
This new report contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
For more information visit http://www.researchandmarkets.com/research/cn59hb/2016_emerging
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
More news releases in similar topics
Share this article